ROBREEM PAIN SOLUTIONS LTD.Active

Company number 10230810Private limited companyIncorporated 2016

Key figures

£310,215+23.1%
Net assets 2025/26
+32.9%
Average annual growth 2020/21–2025/26
0100 k200 k300 k400 k2020/212021/222022/232023/242024/252025/26

Like most small UK companies, ROBREEM PAIN SOLUTIONS LTD. does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k2020/212021/222022/232023/242024/252025/26
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Total assets151,287193,667235,304280,470337,941
Total liabilities19,54832,58830,80328,54126,328
Net assets / total equity131,739161,079204,501251,929310,215
Average number of employees00000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2026

86220

As described in the company's latest filed accounts.

Summary: ROBREEM PAIN SOLUTIONS LTD.

Company

ROBREEM PAIN SOLUTIONS LTD. is a private limited company registered with Companies House under company number 10230810. It was incorporated on 14 Jun 2016. Its status is active. The registered office is in Birmingham (B6). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files micro-entity accounts. Net assets were £310,215, up 23.1% on the previous year. Total assets were £337,941 and total liabilities £26,328. The company had an average of 0 employees. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2027. The next confirmation statement is due by 5 Aug 2027.